Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston blog main
clinical trials
life sciences
national blog main
new york blog main
new york top stories
2
×
rna interference
akcea therapeutics
alirocumab
amgen
andrew fire
biotech
boston
boston top stories
craig mello
drugs
evercore isi
evolocumab
fda
heart attack
hereditary transthyretin amyloidosis
inclisiran
inotersen
john maraganore
joseph swartz
medicines co.
national top stories
new york
nobel prize
onpattro
patisiran
pcsk9 inhibitors
pfizer
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
stroke
What
alnylam
2
×
drug
pharmaceuticals
2
×
afternoon
alnylam’s
approved
based
cholesterol
data
evidence
fda
gets
heart
history
landmark
lasting
long
looms
lowering
making
medco
medicine
medicines
new
ok
onpattro
partner
patisiran
presented
reckoning
rna
rnai
specifically
supporting
term
touts
use
Language
Current search:
alnylam
×
pharmaceuticals
×
" new york top stories "
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
